Iwamoto, Yuichiro
Kimura, Tomohiko
Ohnishi, Mana
Kusano, Takashi
Takenouchi, Haruka
Iwamoto, Hideyuki
Sanada, Junpei
Fushimi, Yoshiro
Katakura, Yukino
Tatsumi, Fuminori
Shimoda, Masashi
Nakanishi, Shuhei
Kaku, Kohei
Mune, Tomoatsu
Kaneto, Hideaki
Article History
Received: 20 May 2023
Accepted: 13 August 2023
First Online: 17 August 2023
Competing interests
: H.K. has received honoraria for lectures, received scholarship grants, and received research grant from Novo Nordisk Pharma, Sanofi, Eli Lilly, Boehringer Ingelheim, Taisho Pharma, Sumitomo Dainippon Pharma, Takeda Pharma, Ono Pharma, Daiichi Sankyo, Mitsubishi Tanabe Pharma, Kissei Pharma, MSD, AstraZeneca, Astellas, Novartis, Kowa, Abbott. K.K. has been an advisor to, received honoraria for lectures from, and received scholarship grants from Novo Nordisk Pharma, Sanwa Kagaku, Takeda, Taisho Pharma, MSD, Kowa, Sumitomo Dainippon Pharma, Novartis, Mitsubishi Tanabe Pharma, AstraZeneca, Boehringer Ingelheim, Chugai, Daiichi Sankyo, Sanofi. All other authors have no conflict of interests.